Meglitinide  Meglitinides stimulate insulin secretion from the beta cells of the pancreas. The process is similar to sulfonylureas, but this form of drugs bind to a different binding site of the beta cell. This drug also has a shorter onset, but also a shorter half life, meaning that the use of this drug is much different. This drug is more effective at decreasing postprandial glucose levels and there is lower risk of hypoglycemia.
 

Medication	Brand Name
Repaglinide	Prandin

prandin

 Home